Community Level Correlates of COVID-19 Booster Vaccine Hesitancy in the United States: A Cross-Sectional Analysis

被引:0
|
作者
Krasner, Henry [1 ]
Harmon, Nicolette [2 ]
Martin, Jeffrey [1 ]
Olaco, Crysty-Ann [1 ]
Netski, Dale M. [3 ,4 ]
Batra, Kavita [4 ,5 ]
机构
[1] Univ Nevada, Kirk Kerkorian Sch Med UNLV, Las Vegas, NV 89102 USA
[2] Univ Nevada, Sch Publ Hlth, Dept Epidemiol & Biostat, Las Vegas, NV 89119 USA
[3] Univ Nevada, Kirk Kerkorian Sch Med UNLV, Las Vegas, NV 89102 USA
[4] Univ Nevada, Kirk Kerkorian Sch Med UNLV, Dept Med Educ, Las Vegas, NV 89102 USA
[5] Univ Nevada, Kirk Kerkorian Sch Med UNLV, Off Res, Las Vegas, NV 89102 USA
关键词
COVID-19; vaccine hesitancy; COVID-19 booster dose; community-level intervention; vaccine literacy; functional literacy; communicative literacy; critical literacy; vaccine confidence index; HEALTH LITERACY; ETHNIC DISPARITIES; POPULATION;
D O I
10.3390/vaccines12020167
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Evidence exists that individual-level sociodemographic factors contribute to vaccine hesitancy, but it is unknown how community-level factors affect COVID-19 booster dose hesitancy. The current study aims to fill this knowledge gap by comparing data from a nationwide survey on COVID-19 vaccine hesitancy with a community-level indicator, i.e., the Distressed Communities Index (DCI). Methods: Attitudes toward vaccinations, vaccine literacy, COVID-19 vaccine confidence index, and trust were measured using a 48-item, psychometrically valid and reliable survey tool. In this study, 2138 survey participants residing in the United States were divided into quintiles of varying community distress levels based on their zip codes using the DCI. Data were analyzed through Chi-square, one-way ANOVA, and post hoc analysis with Tukey's test. Results: A significantly higher proportion of participants from the distressed communities had lower trust than their prosperous counterparts (26.6% vs. 37.6%, p < 0.001). On the contrary, participants from the prosperous communities had significantly higher vaccine confidence index scores than those in distressed communities (2.22 +/- 1.13 vs. 1.70 +/- 1.01, p < 0.001). Conclusions: These findings affirm the importance of developing community-level interventions to promote trust in COVID-19 vaccinations and increase booster dose uptake. From these results, future studies can examine the efficacy of various community-level interventions.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey
    Uhr, Lauren
    Mateen, Farrah J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1072 - 1080
  • [32] COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study
    Lounis, Mohamed
    Bencherit, Djihad
    Rais, Mohammed Amir
    Riad, Abanoub
    VACCINES, 2022, 10 (04)
  • [33] COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
    Yasmin, Farah
    Najeeb, Hala
    Moeed, Abdul
    Naeem, Unaiza
    Asghar, Muhammad Sohaib
    Chughtai, Najeeb Ullah
    Yousaf, Zohaib
    Seboka, Binyam Tariku
    Ullah, Irfan
    Lin, Chung-Ying
    Pakpour, Amir H.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [34] Spatial Modeling of COVID-19 Vaccine Hesitancy in the United States
    Mollalo, Abolfazl
    Tatar, Moosa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (18)
  • [35] Acceptability of COVID-19 booster vaccine in malaysia: a cross-sectional study
    Khoo, Cheryl Minn Jee
    Dea, Eve Zhi Qing
    Law, Li Yeow
    Wong, Sharon Siew Tong
    Ng, Khuen Yen
    Bakhtiar, Athirah
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] Sociopolitical and psychological correlates of COVID-19 vaccine hesitancy in the United States during summer 2021
    Stoler, Justin
    Klofstad, Casey A.
    Enders, Adam M.
    Uscinski, Joseph E.
    SOCIAL SCIENCE & MEDICINE, 2022, 306
  • [37] Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia
    Yahia, Amar Ibrahim Omer
    Alshahrani, Abdullah Mohammed
    Alsulmi, Wael Gabir H.
    Alqarni, Mohammed Mesfer M.
    Abdulrahim, Tamim Khalid Abdullah
    Heba, Waleed Faya H.
    Alqarni, Turki Ayidh A.
    Alharthi, Khalid Ali Z.
    Buhran, Abdullah Ali A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4015 - 4020
  • [38] COVID-19 Vaccine Hesitancy: A Cross-Sectional Study of Visible Minority Canadian Communities
    Ochieng, Candy
    Petrucka, Pammla
    Mutwiri, George
    Szafron, Michael
    VACCINES, 2025, 13 (03)
  • [39] Prevalence & correlates of COVID-19 vaccine hesitancy in a rural community of Bengaluru district, southern India: A preliminary cross-sectional study
    Mundackal, Rose
    Agarwal, Twinkle
    Murali, Karthikk
    Isaac, Natasha, V
    Hu, Patricia
    Dhayal, Vishal
    Mony, Prem K.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (5-6) : 485 - 490
  • [40] COVID-19 vaccine hesitancy in six geopolitical zones in Nigeria: a cross-sectional survey
    Ogunbosi, Babatunde Oluwatosin
    Alao, Michael Abel
    Ibrahim, Olayinka Rasheed
    Ayuk, Adaeze Chikaodinaka
    Ibraheem, Rasheedat Mobolaji
    Odimegwu, Chioma Laura
    Ikwuka, David Chibuike
    Akintan, Patricia
    Morakinyo, OreOluwa
    Adeyemi, Ayomide Toluwanimi
    Jega, Ridwan Muhammad
    Olowookere, Temitayo Folorunso
    Bello, Olaseinde Emmanuel
    Owolabi, Bilkis Iyabo
    Chukwuyem, Abejegah
    Bukar, Lawan Maryah
    Rasaki, Aliu
    Issa, Amudalat
    Ewa, Atana Uket
    Oladokun, Regina
    Akinyinka, Olusegun Olusina
    PAN AFRICAN MEDICAL JOURNAL, 2022, 42